Ramiro Sanchez, Chief Medical Officer at Cerevel Therapeutics Holdings, Inc. (CERE), sold 10,000 shares at $41.37 ($414K) on 2023-12-07, disclosed to the SEC on 2023-12-11.
Scheduled sale ($414k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CERE | SELL | 2023-12-19 | $310K | — | Filing → |